Continuous Glucose Monitoring for Gestational Diabetes
(POSTPOD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes.
Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
Who Is on the Research Team?
Christina Han, MD
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Postpartum Monitoring
Participants are provided a Continuous Glucose Monitor within 2 hours after delivery and wear the device for 24 hours
Postpartum Survey Follow-up
Participants complete surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum
Follow-up
Participants are monitored for safety and effectiveness after initial monitoring
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Glucose Monitor
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Administration of a Continuous Glucose Monitor within 2 hours after delivery for 24-hour collection of glycemic data.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.